|
|
Volumn 127, Issue 2, 2007, Pages 256-259
|
|
Epidermolysis bullosa: From fundamental molecular biology to clinical therapies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHAVBETA6 INTEGRIN;
CYTOKERATIN 14;
GREEN FLUORESCENT PROTEIN;
KALININ;
ORPHAN DRUG;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
RETROVIRUS VECTOR;
SMALL INTERFERING RNA;
TRANSFORMING GROWTH FACTOR BETA1;
TRANSFORMING GROWTH FACTOR BETA2;
UROKINASE RECEPTOR;
BLISTER;
CELL REGENERATION;
CLINICAL ASSESSMENT;
CONFERENCE PAPER;
DERMOEPIDERMAL JUNCTION;
DIAGNOSTIC PROCEDURE;
DRUG SCREENING;
ELECTRON MICROSCOPY;
EPIDERMIS CELL;
EPIDERMOLYSIS BULLOSA;
EPIDERMOLYSIS BULLOSA DYSTROPHICA;
EPIDERMOLYSIS BULLOSA SIMPLEX;
GENE EXPRESSION;
GENE MUTATION;
GENE TARGETING;
GENE THERAPY;
GENETIC DISORDER;
HUMAN;
IMMUNOFLUORESCENCE MICROSCOPY;
IN VITRO STUDY;
IN VIVO STUDY;
LENTIVIRINAE;
MEDICAL LITERATURE;
MEDICAL RESEARCH;
MOLECULAR BIOLOGY;
NONHUMAN;
PRIORITY JOURNAL;
SKIN BIOPSY;
SKIN CELL;
SKIN SURFACE;
SQUAMOUS CELL CARCINOMA;
SYSTEMIC THERAPY;
TISSUE SPECIFICITY;
TRANSGENE;
VIRAL GENE DELIVERY SYSTEM;
WILD TYPE;
WOUND CARE;
CARCINOMA, SQUAMOUS CELL;
EPIDERMOLYSIS BULLOSA;
FIBROBLASTS;
GENE THERAPY;
HUMANS;
MOLECULAR BIOLOGY;
PEPTIDE HYDROLASES;
SKIN NEOPLASMS;
TRANSFORMING GROWTH FACTOR BETA3;
WOUND HEALING;
|
|
EID: 33846242153
PISSN: 0022202X
EISSN: 15231747
Source Type: Journal
DOI: 10.1038/sj.jid.5700731 Document Type: Conference Paper |
|
Times cited : (21)
|
|
References (0)
|
